U.S Class(es): 006, 018, 044, 046, 051, 052
Class Status: Active
Name | Novartis Pharma AG, |
---|---|
Address | Trademark Department Postfach CH-4002 Basel SWITZERLAND |
Date | Description | Action Tags | Code |
---|---|---|---|
Jul-09-2015 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | SDRCM | |
Jul-10-2015 | LIMITATION FROM ORIGINAL APPLICATION ENTERED | LIMII | |
Jul-11-2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | NWOSI | |
Jul-12-2015 | ASSIGNED TO EXAMINER | DOCKD | |
Jul-14-2015 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
Jul-15-2015 | APPLICATION FILING RECEIPT MAILED | MAFRO | |
Jul-29-2015 | NOTICE OF PUBLICATION | NPUBO | |
Aug-12-2015 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | OP2RP | |
Aug-12-2015 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | OPNSP | |
Aug-18-2015 | PUBLISHED FOR OPPOSITION | PUBOA | |
Sep-04-2015 | NOTIFICATION PROCESSED BY IB | GPNXP | |
Oct-23-2015 | DEATH OF INTERNATIONAL REGISTRATION | DETHP | |
Oct-24-2015 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | DENAO | |
Nov-20-2015 | CORRECTION TRANSACTION RECEIVED FROM IB | CRCVM | |
Nov-29-2015 | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | CREVI | |
Apr-19-2017 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | OPNRP | |
Apr-19-2017 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | OPNSP | |
Sep-15-2017 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | OPNXP | |
Aug-07-2018 | REGISTERED-PRINCIPAL REGISTER | R.PRA |